Is there an advantage of using pressure support ventilation with volume guarantee in the initial management of premature infants with respiratory distress syndrome? A pilot study

Suhas M. Nafday, Robert S. Green, Jing Lin, Luc P. Brion, Ian Ochshorn, Ian R. Holzman

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Objective: To evaluate the feasibility of using the pressure support ventilation with volume guarantee (PSV-VG) as an initial ventilatory mode in preterm infants with respiratory distress syndrome (RDS) after surfactant treatment to achieve accelerated weaning of peak inspiratory pressure (PIP) and mean airway pressure (MAP). Study design: Initial 24-hour ventilatory parameters were compared in two groups of preterm infants managed by PSV-VG and the synchronized intermittent mandatory ventilation (SIMV) mode in a randomized controlled pilot study after surfactant treatment for RDS. A total of 16 babies were randomized to PSV-VG (1198±108 g [mean±SEM]; 27.9±0.6 weeks) and 18 babies to SIMV (birth weight 1055±77 g; gestational age 27.4±0.5 weeks). Repeated measures analysis of variance was used to compare serial values of PIP and MAP in the two groups. Results: The PIP and MAP decreased over time (p<0.001) during the first 24 hours after surfactant administration in both groups but the decrease in MAP was faster in the SIMV group compared to PSV-VG group (p = 0.035) The median numbers of blood gases during the first 24 hours were four and two in the SIMV and PSV-VG groups, respectively (p<0.001). The overall outcomes were not significantly different between the two groups. Conclusion: PSV-VG did not offer any ventilatory advantage over SIMV in the initial management of sufactant-treated premature newborns with RDS except for minimizing the number of blood gases.

Original languageEnglish (US)
Pages (from-to)193-197
Number of pages5
JournalJournal of Perinatology
Volume25
Issue number3
DOIs
StatePublished - Mar 2005

Fingerprint

Newborn Respiratory Distress Syndrome
Premature Infants
Ventilation
Pressure
Surface-Active Agents
Gases
Weaning
Birth Weight
Gestational Age

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

Is there an advantage of using pressure support ventilation with volume guarantee in the initial management of premature infants with respiratory distress syndrome? A pilot study. / Nafday, Suhas M.; Green, Robert S.; Lin, Jing; Brion, Luc P.; Ochshorn, Ian; Holzman, Ian R.

In: Journal of Perinatology, Vol. 25, No. 3, 03.2005, p. 193-197.

Research output: Contribution to journalArticle

@article{e8208bb7459348a0b161eb4cb17580de,
title = "Is there an advantage of using pressure support ventilation with volume guarantee in the initial management of premature infants with respiratory distress syndrome? A pilot study",
abstract = "Objective: To evaluate the feasibility of using the pressure support ventilation with volume guarantee (PSV-VG) as an initial ventilatory mode in preterm infants with respiratory distress syndrome (RDS) after surfactant treatment to achieve accelerated weaning of peak inspiratory pressure (PIP) and mean airway pressure (MAP). Study design: Initial 24-hour ventilatory parameters were compared in two groups of preterm infants managed by PSV-VG and the synchronized intermittent mandatory ventilation (SIMV) mode in a randomized controlled pilot study after surfactant treatment for RDS. A total of 16 babies were randomized to PSV-VG (1198±108 g [mean±SEM]; 27.9±0.6 weeks) and 18 babies to SIMV (birth weight 1055±77 g; gestational age 27.4±0.5 weeks). Repeated measures analysis of variance was used to compare serial values of PIP and MAP in the two groups. Results: The PIP and MAP decreased over time (p<0.001) during the first 24 hours after surfactant administration in both groups but the decrease in MAP was faster in the SIMV group compared to PSV-VG group (p = 0.035) The median numbers of blood gases during the first 24 hours were four and two in the SIMV and PSV-VG groups, respectively (p<0.001). The overall outcomes were not significantly different between the two groups. Conclusion: PSV-VG did not offer any ventilatory advantage over SIMV in the initial management of sufactant-treated premature newborns with RDS except for minimizing the number of blood gases.",
author = "Nafday, {Suhas M.} and Green, {Robert S.} and Jing Lin and Brion, {Luc P.} and Ian Ochshorn and Holzman, {Ian R.}",
year = "2005",
month = "3",
doi = "10.1038/sj.jp.7211233",
language = "English (US)",
volume = "25",
pages = "193--197",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Is there an advantage of using pressure support ventilation with volume guarantee in the initial management of premature infants with respiratory distress syndrome? A pilot study

AU - Nafday, Suhas M.

AU - Green, Robert S.

AU - Lin, Jing

AU - Brion, Luc P.

AU - Ochshorn, Ian

AU - Holzman, Ian R.

PY - 2005/3

Y1 - 2005/3

N2 - Objective: To evaluate the feasibility of using the pressure support ventilation with volume guarantee (PSV-VG) as an initial ventilatory mode in preterm infants with respiratory distress syndrome (RDS) after surfactant treatment to achieve accelerated weaning of peak inspiratory pressure (PIP) and mean airway pressure (MAP). Study design: Initial 24-hour ventilatory parameters were compared in two groups of preterm infants managed by PSV-VG and the synchronized intermittent mandatory ventilation (SIMV) mode in a randomized controlled pilot study after surfactant treatment for RDS. A total of 16 babies were randomized to PSV-VG (1198±108 g [mean±SEM]; 27.9±0.6 weeks) and 18 babies to SIMV (birth weight 1055±77 g; gestational age 27.4±0.5 weeks). Repeated measures analysis of variance was used to compare serial values of PIP and MAP in the two groups. Results: The PIP and MAP decreased over time (p<0.001) during the first 24 hours after surfactant administration in both groups but the decrease in MAP was faster in the SIMV group compared to PSV-VG group (p = 0.035) The median numbers of blood gases during the first 24 hours were four and two in the SIMV and PSV-VG groups, respectively (p<0.001). The overall outcomes were not significantly different between the two groups. Conclusion: PSV-VG did not offer any ventilatory advantage over SIMV in the initial management of sufactant-treated premature newborns with RDS except for minimizing the number of blood gases.

AB - Objective: To evaluate the feasibility of using the pressure support ventilation with volume guarantee (PSV-VG) as an initial ventilatory mode in preterm infants with respiratory distress syndrome (RDS) after surfactant treatment to achieve accelerated weaning of peak inspiratory pressure (PIP) and mean airway pressure (MAP). Study design: Initial 24-hour ventilatory parameters were compared in two groups of preterm infants managed by PSV-VG and the synchronized intermittent mandatory ventilation (SIMV) mode in a randomized controlled pilot study after surfactant treatment for RDS. A total of 16 babies were randomized to PSV-VG (1198±108 g [mean±SEM]; 27.9±0.6 weeks) and 18 babies to SIMV (birth weight 1055±77 g; gestational age 27.4±0.5 weeks). Repeated measures analysis of variance was used to compare serial values of PIP and MAP in the two groups. Results: The PIP and MAP decreased over time (p<0.001) during the first 24 hours after surfactant administration in both groups but the decrease in MAP was faster in the SIMV group compared to PSV-VG group (p = 0.035) The median numbers of blood gases during the first 24 hours were four and two in the SIMV and PSV-VG groups, respectively (p<0.001). The overall outcomes were not significantly different between the two groups. Conclusion: PSV-VG did not offer any ventilatory advantage over SIMV in the initial management of sufactant-treated premature newborns with RDS except for minimizing the number of blood gases.

UR - http://www.scopus.com/inward/record.url?scp=16244391148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16244391148&partnerID=8YFLogxK

U2 - 10.1038/sj.jp.7211233

DO - 10.1038/sj.jp.7211233

M3 - Article

C2 - 15674409

AN - SCOPUS:16244391148

VL - 25

SP - 193

EP - 197

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 3

ER -